A cheap antidepressant reduced the need for hospitalization among high-risk adults with Covid-19 in a study hunting for existing drugs that could be repurposed to treat coronavirus.
and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.
“If WHO recommends this, you will see it widely taken up,” said study co-author Dr. Edward Mills of McMaster University in Hamilton, Ontario, adding that many poor nations have the drug readily available. “We hope it will lead to a lot of lives saved.”The pill, called fluvoxamine, would cost $4 for a course of Covid treatment. By comparison, antibody IV treatments cost about $2,000 and Merck's experimental antiviral pill for Covid is about $700 per course.
In the group that took the drug, 11 percent needed hospitalization or an extended ER stay, compared to 16 percent of those on dummy pills.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Covid-19: Record case rates in Wales and long Covid study begins in ScotlandFive things you need to know about the coronavirus pandemic this Tuesday evening.
Les mer »
Cheap, generic antidepressant shows promise in treating early COVID-19A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing drugs that could be...
Les mer »
Covid-19 vaccine rates for kids echo regional disparities, worrying doctorsWhether children receive a dose of a Covid-19 vaccine often depends on where they call home.
Les mer »
How COVID-19 in kids compares to the flu, other viruses in childrenCOVID-19 isn’t the only viral disease children are catching this year. Influenza, which sends thousands of children to the hospital each season, is predicted to ramp up in the coming months.
Les mer »